Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

Alopecia areata in infants may be more common than previously thought.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

The review says skin conditions with sterile pustules need more research for better treatments.

Toxic shock syndrome is caused by a complex interaction of bacterial toxins and the immune system, and understanding this can help improve diagnosis and treatment.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

Minoxidil can cause deadly skin reaction; monitor patients closely.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

A woman experienced rapid hair loss after taking albendazole, but it started to improve when she stopped the medication.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Early identification of lupus through skin signs and blood tests is crucial in India.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Skin symptoms are important for diagnosing infections in children.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

New treatments and understanding of skin lupus are emerging in 2024.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.